Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness

NCT06796361 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Ketanserin 40mg plus Psilocybin 40mg
DRUG: 40mg Psilocybin
DRUG: 20mg Psilocybin
DRUG: 10mg Psilocybin
DRUG: 5mg Psilocybin
OTHER: Placebo

Sponsor

University Hospital, Basel, Switzerland